Lakeland Industries, Inc. (NASDAQ:LAKE) Receives Consensus Rating of “Hold” from Analysts

Shares of Lakeland Industries, Inc. (NASDAQ:LAKE) have been assigned an average rating of “Hold” from the five analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $15.20.

LAKE has been the topic of a number of research reports. Lake Street Capital decreased their target price on shares of Lakeland Industries from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Friday, April 17th. DA Davidson raised shares of Lakeland Industries from a “neutral” rating to a “buy” rating and raised their target price for the stock from $10.00 to $14.00 in a research note on Monday, April 20th. Wall Street Zen raised shares of Lakeland Industries from a “strong sell” rating to a “sell” rating in a research report on Saturday. Finally, Maxim Group set a $16.00 price target on shares of Lakeland Industries in a research report on Monday, April 20th.

Lakeland Industries Trading Up 1.4%

LAKE opened at $9.54 on Wednesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.53 and a quick ratio of 1.36. The company’s 50 day simple moving average is $9.87 and its two-hundred day simple moving average is $9.87. Lakeland Industries has a 1-year low of $7.15 and a 1-year high of $18.00. The firm has a market capitalization of $94.06 million, a price-to-earnings ratio of -3.70 and a beta of 1.45.

Lakeland Industries (NASDAQ:LAKE) last released its earnings results on Tuesday, June 9th. The medical instruments supplier reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.18. Lakeland Industries had a negative net margin of 13.14% and a negative return on equity of 9.57%. The business had revenue of $47.42 million for the quarter, compared to analyst estimates of $47.36 million. Analysts expect that Lakeland Industries will post 0.25 EPS for the current fiscal year.

Institutional Trading of Lakeland Industries

Several institutional investors have recently made changes to their positions in the company. BNP Paribas Financial Markets raised its position in shares of Lakeland Industries by 87.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,795 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 839 shares during the period. First Trust Advisors LP raised its position in shares of Lakeland Industries by 4.2% during the 2nd quarter. First Trust Advisors LP now owns 28,554 shares of the medical instruments supplier’s stock valued at $389,000 after buying an additional 1,149 shares during the period. Bank of New York Mellon Corp raised its position in shares of Lakeland Industries by 2.0% during the 1st quarter. Bank of New York Mellon Corp now owns 75,107 shares of the medical instruments supplier’s stock valued at $615,000 after buying an additional 1,479 shares during the period. Rhumbline Advisers raised its position in shares of Lakeland Industries by 16.0% during the 3rd quarter. Rhumbline Advisers now owns 13,415 shares of the medical instruments supplier’s stock valued at $199,000 after buying an additional 1,853 shares during the period. Finally, Wells Fargo & Company MN raised its position in shares of Lakeland Industries by 35.5% during the 4th quarter. Wells Fargo & Company MN now owns 9,514 shares of the medical instruments supplier’s stock valued at $84,000 after buying an additional 2,492 shares during the period. Hedge funds and other institutional investors own 71.69% of the company’s stock.

About Lakeland Industries

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.